89bio, Inc. (ETNB)
NASDAQ: ETNB · IEX Real-Time Price · USD
8.35
+0.02 (0.24%)
At close: Jul 19, 2024, 4:00 PM
8.36
+0.01 (0.12%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
89bio Market Cap
89bio has a market cap or net worth of $821.51 million as of July 22, 2024. Its market cap has decreased by -39.13% in one year.
Market Cap
821.51M
Enterprise Value
286.52M
1-Year Change
-39.13%
Ranking
Category
Stock Price
$8.35
Market Cap Chart
Since November 11, 2019, 89bio's market cap has increased from $250.90M to $821.51M, an increase of 227.42%. That is a compound annual growth rate of 28.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 821.50M | -2.77% |
| Dec 29, 2023 | 844.90M | 42.62% |
| Dec 30, 2022 | 592.40M | 123.46% |
| Dec 31, 2021 | 265.10M | -45.27% |
| Dec 31, 2020 | 484.40M | 33.63% |
| Dec 31, 2019 | 362.50M | 44.48% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GeneDx Holdings | 832.38M |
| InnovAge Holding | 825.45M |
| Mesoblast | 825.11M |
| Cogent Biosciences | 823.23M |
| CureVac | 823.20M |
| The Pennant Group | 815.44M |
| Standard BioTools | 811.22M |
| Clover Health Investments | 809.19M |